作者
Sanjeewa A Goonasekera, Chi K Lam, Douglas P Millay, Michelle A Sargent, Roger J Hajjar, Evangelia G Kranias, Jeffery D Molkentin
发表日期
2011/3/1
期刊
The Journal of clinical investigation
卷号
121
期号
3
页码范围
1044-1052
出版商
American Society for Clinical Investigation
简介
Muscular dystrophies (MDs) comprise a group of degenerative muscle disorders characterized by progressive muscle wasting and often premature death. The primary defect common to most MDs involves disruption of the dystrophin-glycoprotein complex (DGC). This leads to sarcolemmal instability and Ca2+ influx, inducing cellular necrosis. Here we have shown that the dystrophic phenotype observed in δ-sarcoglycan–null (Sgcd–/–) mice and dystrophin mutant mdx mice is dramatically improved by skeletal muscle–specific overexpression of sarcoplasmic reticulum Ca2+ ATPase 1 (SERCA1). Rates of myofiber central nucleation, tissue fibrosis, and serum creatine kinase levels were dramatically reduced in Sgcd–/– and mdx mice with the SERCA1 transgene, which also rescued the loss of exercise capacity in Sgcd–/– mice. Adeno-associated virus–SERCA2a (AAV-SERCA2a) gene therapy in the gastrocnemius …
引用总数
201120122013201420152016201720182019202020212022202320246142328221218181614162177
学术搜索中的文章
SA Goonasekera, CK Lam, DP Millay, MA Sargent… - The Journal of clinical investigation, 2011